Cancer Research AACR Membership  Frontiers in Basic Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kirschmann, D. A.
Right arrow Articles by Hendrix, M. J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kirschmann, D. A.
Right arrow Articles by Hendrix, M. J. C.
[Cancer Research 62, 4478-4483, August 1, 2002]
© 2002 American Association for Cancer Research


Tumor Biology

A Molecular Role for Lysyl Oxidase in Breast Cancer Invasion1

Dawn A. Kirschmann2, Elisabeth A. Seftor, Sheri F. T. Fong, Daniel R. C. Nieva, Colleen M. Sullivan, Elijah M. Edwards, Pascal Sommer, Katalin Csiszar and Mary J. C. Hendrix

Department of Anatomy and Cell Biology, Holden Comprehensive Cancer Center at The University of Iowa, The Roy J. and Lucille A. Carver College of Medicine, Iowa City, Iowa 52242-1109 [D. A. K., E. A. S., D. R. C. N., C. M. S., E. M. E., M. J. C. H.]; Institut de Biologie et Chimie des Protéines, Lyon Cedex 07, France [P. S.]; and Pacific Biomedical Research Center, University of Hawaii, Honolulu, Hawaii 96822 [S. F. T. F., K. C.]

We identified previously an up-regulation in lysyl oxidase (LOX) expression,an extracellular matrix remodeling enzyme, in a highly invasive/metastatic human breast cancer cell line, MDA-MB-231, compared with MCF-7, a poorly invasive/nonmetastatic breast cancer cell line. In this study, we demonstrate that the mRNA expression of LOX and other LOX family members [lysyl oxidase-like (LOXL), LOXL2, LOXL3, and LOXL4] was observed only in breast cancer cells with a highly invasive/metastatic phenotype but not in poorly invasive/nonmetastatic breast cancer cells. LOX and LOXL2 showed the strongest association with invasive potential in both highly invasive/metastatic breast cancer cell lines tested (MDA-MB-231 and Hs578T). To determine whether LOX is directly involved in breast cancer invasion, LOX antisense oligonucleotides were transfected into MDA-MB-231 and Hs578T cells, and found to inhibit invasion through a collagen IV/laminin/gelatin matrix in vitro compared with LOX sense oligonucleotide-treated and untreated controls. In addition, treatment of MDA-MB-231 and Hs578T cells with ß-aminopropionitrile (an irreversible inhibitor of LOX enzymatic activity) decreased invasive activity. Conversely, MCF-7 cells transfected with the murine LOX gene demonstrated a 2-fold increase in invasiveness that was reversible by the addition of ß-aminopropionitrile in a dose-dependent manner. In addition, endogenous LOX mRNA expression was induced when MCF-7 cells were cultured in the presence of fibroblast conditioned medium or conditioned matrix, suggesting a role for stromal fibroblasts in LOX regulation in breast cancer cells. Moreover, the correlation of LOX up-regulation and invasive/metastatic potential was additionally demonstrated in rat prostatic tumor cell lines, and human cutaneous and uveal melanoma cell lines. These results provide substantial new evidence that LOX is involved in cancer cell invasion.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
Y.-H. Lee, A. R. Albig, M. Regner, B. J. Schiemann, and W. P. Schiemann
Fibulin-5 initiates epithelial-mesenchymal transition (EMT) and enhances EMT induced by TGF-{beta} in mammary epithelial cells via a MMP-dependent mechanism
Carcinogenesis, December 1, 2008; 29(12): 2243 - 2251.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. A. Lucero, K. Ravid, J. L. Grimsby, C. B. Rich, S. J. DiCamillo, J. M. Maki, J. Myllyharju, and H. M. Kagan
Lysyl Oxidase Oxidizes Cell Membrane Proteins and Enhances the Chemotactic Response of Vascular Smooth Muscle Cells
J. Biol. Chem., August 29, 2008; 283(35): 24103 - 24117.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Peinado, G. Moreno-Bueno, D. Hardisson, E. Perez-Gomez, V. Santos, M. Mendiola, J. I. de Diego, M. Nistal, M. Quintanilla, F. Portillo, et al.
Lysyl Oxidase-Like 2 as a New Poor Prognosis Marker of Squamous Cell Carcinomas
Cancer Res., June 15, 2008; 68(12): 4541 - 4550.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
C. M. Bailey, D. E. Abbott, N. V. Margaryan, Z. Khalkhali-Ellis, and M. J. C. Hendrix
Interferon Regulatory Factor 6 Promotes Cell Cycle Arrest and Is Regulated by the Proteasome in a Cell Cycle-Dependent Manner
Mol. Cell. Biol., April 1, 2008; 28(7): 2235 - 2243.
[Abstract] [Full Text] [PDF]


Home page
Integr Cancer TherHome page
C. Guruvayoorappan and G. Kuttan
Biophytum sensitivum (L.) DC Inhibits Tumor Cell Invasion and Metastasis Through a Mechanism Involving Regulation of MMPs, Prolyl Hydroxylase, Lysyl Oxidase, nm23, ERK-1, ERK-2, STAT-1, and Proinflammatory Cytokine Gene Expression in Metastatic Lung Tissue
Integr Cancer Ther, March 1, 2008; 7(1): 42 - 50.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
S. Gao, Y. Zhao, L. Kong, P. Toselli, I.-N. Chou, P. Stone, and W. Li
Cloning and Characterization of the Rat Lysyl Oxidase Gene Promoter: IDENTIFICATION OF CORE PROMOTER ELEMENTS AND FUNCTIONAL NUCLEAR FACTOR I-BINDING SITES
J. Biol. Chem., August 31, 2007; 282(35): 25322 - 25337.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
T.-M. Shieh, S.-C. Lin, C.-J. Liu, S.-S. Chang, T.-H. Ku, and K.-W. Chang
Association of Expression Aberrances and Genetic Polymorphisms of Lysyl Oxidase with Areca-Associated Oral Tumorigenesis
Clin. Cancer Res., August 1, 2007; 13(15): 4378 - 4385.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
Y. Guo, N. Pischon, A. H. Palamakumbura, and P. C. Trackman
Intracellular distribution of the lysyl oxidase propeptide in osteoblastic cells
Am J Physiol Cell Physiol, June 1, 2007; 292(6): C2095 - C2102.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. Wu, Z. Guo, X. Chang, M. S. Kim, J. K. Nagpal, J. Liu, J. M. Maki, K. I. Kivirikko, S. P. Ethier, B. Trink, et al.
LOXL1 and LOXL4 Are Epigenetically Silenced and Can Inhibit Ras/Extracellular Signal-Regulated Kinase Signaling Pathway in Human Bladder Cancer
Cancer Res., May 1, 2007; 67(9): 4123 - 4129.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Polgar, B. Fogelgren, J. M. Shipley, and K. Csiszar
Lysyl Oxidase Interacts with Hormone Placental Lactogen and Synergistically Promotes Breast Epithelial Cell Proliferation and Migration
J. Biol. Chem., February 2, 2007; 282(5): 3262 - 3272.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Min, K. H. Kirsch, Y. Zhao, S. Jeay, A. H. Palamakumbura, P. C. Trackman, and G. E. Sonenshein
The Tumor Suppressor Activity of the Lysyl Oxidase Propeptide Reverses the Invasive Phenotype of Her-2/neu-Driven Breast Cancer
Cancer Res., February 1, 2007; 67(3): 1105 - 1112.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. T. Erler and A. J. Giaccia
Lysyl Oxidase Mediates Hypoxic Control of Metastasis
Cancer Res., November 1, 2006; 66(21): 10238 - 10241.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
O. Aprelikova, M. Wood, S. Tackett, G. V.R. Chandramouli, and J. C. Barrett
Role of ETS Transcription Factors in the Hypoxia-Inducible Factor-2 Target Gene Selection
Cancer Res., June 1, 2006; 66(11): 5641 - 5647.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. Bouez, C. Reynaud, E. Noblesse, A. Thepot, C. Gleyzal, J. Kanitakis, E. Perrier, O. Damour, and P. Sommer
The Lysyl Oxidase LOX Is Absent in Basal and Squamous Cell Carcinomas and Its Knockdown Induces an Invading Phenotype in a Skin Equivalent Model
Clin. Cancer Res., March 1, 2006; 12(5): 1463 - 1469.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
M. Gronborg, T. Z. Kristiansen, A. Iwahori, R. Chang, R. Reddy, N. Sato, H. Molina, O. N. Jensen, R. H. Hruban, M. G. Goggins, et al.
Biomarker Discovery from Pancreatic Cancer Secretome Using a Differential Proteomic Approach
Mol. Cell. Proteomics, January 1, 2006; 5(1): 157 - 171.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. L. Payne, B. Fogelgren, A. R. Hess, E. A. Seftor, E. L. Wiley, S. F.T. Fong, K. Csiszar, M. J.C. Hendrix, and D. A. Kirschmann
Lysyl Oxidase Regulates Breast Cancer Cell Migration and Adhesion through a Hydrogen Peroxide-Mediated Mechanism
Cancer Res., December 15, 2005; 65(24): 11429 - 11436.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. M. Bailey, Z. Khalkhali-Ellis, S. Kondo, N. V. Margaryan, R. E. B. Seftor, W. W. Wheaton, S. Amir, M. R. Pins, B. C. Schutte, and M. J. C. Hendrix
Mammary Serine Protease Inhibitor (Maspin) Binds Directly to Interferon Regulatory Factor 6: IDENTIFICATION OF A NOVEL SERPIN PARTNERSHIP
J. Biol. Chem., October 7, 2005; 280(40): 34210 - 34217.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
A. C. Borczuk, H. K. Kim, H. A. Yegen, R. A. Friedman, and C. A. Powell
Lung Adenocarcinoma Global Profiling Identifies Type II Transforming Growth Factor-{beta} Receptor as a Repressor of Invasiveness
Am. J. Respir. Crit. Care Med., September 15, 2005; 172(6): 729 - 737.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Molnar, Z. Ujfaludi, S. F. T. Fong, J. A. Bollinger, G. Waro, B. Fogelgren, D. M. Dooley, M. Mink, and K. Csiszar
Drosophila Lysyl Oxidases Dmloxl-1 and Dmloxl-2 Are Differentially Expressed and the Active DmLOXL-1 Influences Gene Expression and Development
J. Biol. Chem., June 17, 2005; 280(24): 22977 - 22985.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Utomo, X. Jiang, S. Furuta, J. Yun, D. S. Levin, Y.-C. J. Wang, K. V. Desai, J. E. Green, P.-L. Chen, and W.-H. Lee
Identification of a Novel Putative Non-selenocysteine Containing Phospholipid Hydroperoxide Glutathione Peroxidase (NPGPx) Essential for Alleviating Oxidative Stress Generated from Polyunsaturated Fatty Acids in Breast Cancer Cells
J. Biol. Chem., October 15, 2004; 279(42): 43522 - 43529.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Kaneda, K. Wakazono, T. Tsukamoto, N. Watanabe, Y. Yagi, M. Tatematsu, M. Kaminishi, T. Sugimura, and T. Ushijima
Lysyl Oxidase Is a Tumor Suppressor Gene Inactivated by Methylation and Loss of Heterozygosity in Human Gastric Cancers
Cancer Res., September 15, 2004; 64(18): 6410 - 6415.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Lapointe, C. Li, J. P. Higgins, M. van de Rijn, E. Bair, K. Montgomery, M. Ferrari, L. Egevad, W. Rayford, U. Bergerheim, et al.
Gene expression profiling identifies clinically relevant subtypes of prostate cancer
PNAS, January 20, 2004; 101(3): 811 - 816.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. Akiri, E. Sabo, H. Dafni, Z. Vadasz, Y. Kartvelishvily, N. Gan, O. Kessler, T. Cohen, M. Resnick, M. Neeman, et al.
Lysyl Oxidase-related Protein-1 Promotes Tumor Fibrosis and Tumor Progression in Vivo
Cancer Res., April 1, 2003; 63(7): 1657 - 1666.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.